Torrance, United States
Enovachem Pharmaceuticals, founded in 2009, is a prominent player in the pharmaceutical sector, specializing in contract packaging and repackaging. With its headquarters in the United States, the company operates within the Manufacturing and Pharmaceutical industries.
Renowned as a leader, Enovachem serves a diverse client base, including physicians, pharmacies, manufacturers, wholesalers, and distributors. It delivers services across a range of products such as OTC items, supplements, cosmetics, prescription drugs, and controlled substances ranging from C-III to C-V. Its compliance with cGMP and CFR standards, along with FDA and DEA registration, ensures high-quality operations.
Notably, Enovachem was acquired by Novatim Equity Partners in 2014. Despite its robust industry presence, there has been no recent investment activity noted, which may present both challenges and opportunities for future investors looking to partner with an established entity in pharmaceutical manufacturing.
